PRAX - Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which is currently in Phase IIa clinical trials for addressing both major depressive disorder and perimenopausal depression.
As of Jun 26, 2026: spot at $317.58, ATM IV 56.8%, max pain $300.00, net GEX -$653.6K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $6.93B
- Beta
- 2.75
- 52-Week Range
- 37.19-366.52
- CEO
- Marcio Silva De'Souza
- Employees
- 116
- IPO Date
- Oct 16, 2020
- Exchange
- NASDAQ
What PRAX Looks Like to Options Traders Today
IV rank of 3.2% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$653.6K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.000) is roughly flat across the wings.
What This Page Covers
The PRAX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked PRAX overview questions
- What is PRAX?
- PRAX is the ticker symbol for Praxis Precision Medicines, Inc., a listed security. Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. Listed on NASDAQ. PRAX is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the PRAX options snapshot look like today?
- As of Jun 26, 2026, the PRAX options snapshot shows spot at $317.58, ATM IV 56.8%, IV rank 3.2%, max pain $300.00, net GEX -$653.6K, expected move 16.28%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are PRAX's key statistics?
- Praxis Precision Medicines, Inc. (PRAX) carries a market capitalization of $6.93B, beta of 2.75 relative to the broader market, 52-week range of 37.19-366.52. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does PRAX belong to?
- Praxis Precision Medicines, Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare PRAX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the PRAX data on this page?
- The options snapshot above is dated Jun 26, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).